EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Innovative Clinical Trial Approach for Evaluating Digital Medical Devices Under European Fast‐Track Regulatory Frameworks

Moreno Ursino iD, Sandrine Boulet, Corinne Collignon, Florence Francis-Oliviero, Edouard Lhomme, Raphaël Porcher iD, Florence Saillour, Gaël Varoquaux, Vincent Vercamer, Rodolphe Thiébaut, Sarah Zohar

Statistics in Medicine · 2026-05 · 45 (10-12)

DOI: 10.1002/sim.70572 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistics in Medicine, online erschienen am 05.05.2026. Verfasst von Moreno Ursino und 10 weiteren Autor:innen. Beteiligte Einrichtung: Inserm, Inria, Université Paris Cité, UMRS 1346, HeKA, Paris, France. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Technology Assessment, Biomedical. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To address patient demand for rapid access to innovative digital medical devices (DMDs), several health technology assessment (HTA) authorities in European Union countries provide transitional or provisional access and reimbursement pathways. These pathways are available when only incomplete clinical trial data are accessible, and significant uncertainty remains regarding the clinical benefits, even after CE (European conformity) marking has been obtained. Once manufacturers complete the clinical studies, additional real‐world data (RWD) may become available as a result of the device's use in the target population. Consequently, regulators can draw on both sources of information to support their final decision‐making processes. For a statistically principled evaluation of such settings, we propose a statistical framework suitable for DMD evaluation under European HTA fast‐track requirements, integrating both clinical trial data and RWD. The framework consists of three key steps: (1) an interim analysis of clinical trial data, which can support temporary regulatory authorization and enable the collection of RWD; (2) a final analysis of the clinical trial data; and (3) a meta‐analysis combining the clinical trial data and RWD, contingent upon obtaining temporary authorization. To optimize the timing of the interim analysis and the application for temporary authorization, we introduce several metrics. The proposed framework was assessed by means of an extensive simulation study. This framework should be complemented by a post‐market evaluation of the DMD once it has been widely adopted, aligning with the principles of phase IV studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicTechnology Assessment, BiomedicalHumansEuropean UnionDigital HealthEuropeMeta-Analysis as Topic

Stichwörter der Autor:innen

Bayesianinterim analysismeta‐analysisrandomized clinical trialreal‐world data

Autor:innen und Institutionen

  • Inserm, Inria, Université Paris Cité, UMRS 1346, HeKA, Paris, France.
  • Haute Autorité de santé, Saint Denis, France.
  • Université de Bordeaux, ISPED, INSERM, Bordeaux Population Health Research Center, U1219, Bordeaux, France.
  • Service d'Information Médicale, CHU de Bordeaux, Bordeaux, France.
  • Inria, SISTM, Bordeaux, France.
  • Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, Center for Research in Epidemiology and Statistics (CRESS), Paris, France.

ORCID-Profile: Moreno Ursino, Raphaël Porcher

Förderung

  • Agence Nationale de la Recherche

Zitieren

APA

Ursino, M., Boulet, S., Collignon, C., Francis-Oliviero, F., Lhomme, E., Porcher, R., Saillour, F., Varoquaux, G., Vercamer, V., Thiébaut, R., & Zohar, S. (2026). Innovative Clinical Trial Approach for Evaluating Digital Medical Devices Under European Fast‐Track Regulatory Frameworks. Statistics in Medicine, 45(10-12). https://doi.org/10.1002/sim.70572

Vancouver

Ursino M, Boulet S, Collignon C, Francis-Oliviero F, Lhomme E, Porcher R, et al. Innovative Clinical Trial Approach for Evaluating Digital Medical Devices Under European Fast‐Track Regulatory Frameworks. Statistics in Medicine. 2026;45(10-12). doi:10.1002/sim.70572

BibTeX
@article{Ursino2026,
  author = {Ursino, Moreno and Boulet, Sandrine and Collignon, Corinne and Francis-Oliviero, Florence and Lhomme, Edouard and Porcher, Raphaël and Saillour, Florence and Varoquaux, Gaël and Vercamer, Vincent and Thiébaut, Rodolphe and Zohar, Sarah},
  title = {Innovative Clinical Trial Approach for Evaluating Digital Medical Devices Under European Fast‐Track Regulatory Frameworks},
  journal = {Statistics in Medicine},
  year = {2026},
  volume = {45},
  number = {10-12},
  doi = {10.1002/sim.70572}
}
Kostenlos starten →